Abstract
For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 438-518 |
| Number of pages | 81 |
| Journal | American Journal of Transplantation |
| Volume | 22 |
| Issue number | S2 |
| DOIs | |
| State | Published - Mar 2022 |
Bibliographical note
Publisher Copyright:© John Wiley & Sons, Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- End-stage lung disease
- LAS
- lung allocation score
- lung transplant
- organ allocation
- revised lung allocation score
- transplant outcomes
Fingerprint
Dive into the research topics of 'OPTN/SRTR 2020 Annual Data Report: Lung'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS